Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Small cell lung cancer
Closed
Phase 2
This trial is looking at whether a supplement powder given in combination with a support programme can help stop a weight and muscle loss condition called cachexia (pronounced kak-ek-see-ah).
If you have been diagnosed with lung cancer, it is possible that you may lose weight and feel very weak even though you are eating well. This can be part of a process that affects some people with cancer. It is called cachexia.
Researchers in this trial want to see if mixing a supplement powder into drink will help stop people losing weight and muscle strength. The supplement contains substances that the researchers hope will help to stop muscle breakdown. People taking part in this trial will join a support programme to help medical staff pick up and treat any symptoms of cachexia. Half the group will also take the supplement for 12 weeks. The team will measure weight and muscle strength and see if results are better in those taking the supplement. The main aims of this trial are to
See if this supplement can prevent people with lung cancer losing weight and muscle strength
Find out why some people with cancer are more at risk of weight loss than others.
Recruitment start: 17 January 2012
Recruitment end: 1 August 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Joyce Thompson
Experimental Cancer Medicine Centre (ECMC)
Marie Curie Cancer Care
NIHR Clinical Research Network: Cancer
National Cancer Research Institute (NCRI) Supportive and Palliative Care (SuPaC)
University of Birmingham
Last reviewed: 03 Apr 2016
CRUK internal database number: 3631